MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).
- Status
- COMPLETED
- Phase
- PHASE1
Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
- Status
- SUSPENDED
- Phase
- PHASE3
A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ruxolitinib in Pancreatic Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis
- Status
- COMPLETED
- Phase
- PHASE2
Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker
- Status
- UNKNOWN
- Phase
- NA
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3